Advanced glycation end products formation inhibition through standardized crude extract of punica granatum L. stem bark by Khangholi, Shahpour
  
ADVANCED GLYCATION END PRODUCTS FORMATION INHIBITION 
THROUGH STANDARDIZED CRUDE EXTRACT OF PUNICA      
GRANATUM L. STEM BARK 
 
SHAHPOUR KHANGHOLI 
 
A thesis submitted in fulfilment of the  
requirements for the award of the degree of  
Doctor of Philosophy (Bioprocess Engineering) 
 
Faculty of Chemical and Energy Engineeringg  
Universiti Teknologi Malaysia 
 
OCTOBER 2017 
  
iii 
 
 
 DEDICATION 
 
 
 
 
 
I would like to dedicate the thesis to my beloved parents, my 
dearest Bahar and Melika, and especially my love and wife, 
Maryam, for always loving, understanding, encouraging and 
supporting me. Words cannot express my gratitude for having        
them as my family. 
  
iv 
 
 
 ACKNOWLEDGEMENTS 
In first and foremost, I wish to express my most sincere appreciation to my 
supervisor, Prof. Dr Fadzilah Adibah Abdul Majid, for the opportunity of being part 
of her research laboratory member and also for the guidance, challenges and support 
that she provided during my research which allowed me to further my knowledge, 
experience and career. I was taught to carry out the research in a scientifically 
logical way, and be enthusiastic and optimistic in the face of any challenges. I truly 
appreciate my co-supervisors Prof. Ramlan Aziz and Assoc. Prof. Farediah Ahmad 
for their advice on my research during my whole Ph.D. study. I also thank the Tissue 
Culture Engineering Research Group members for their friendship, support and 
guidance throughout my study especially Hassan Fahmi Bin Ismail, Patrick Ong Yit 
Han, Teh Liam Chee, Norsamsiah binti Muhamad, Mohsen Marvi Beigi, Hala A. K. 
Rasheed. I also thank Dr. Hamid Kashefi for his advice and counsel on statistical 
analysis. I also would like to thank Institute of Bioproduct Development and applied 
physiology laboratory for providing materials and equipment for performing some 
part of the study. I would also like to thank the Universiti Teknologi Malaysia 
(UTM) for its favorable academic atmosphere which makes me enjoy my research. I 
also would like to acknowledge Shahed University for financial supporting me to 
pursue a graduate degree. Last but not least, my deepest gratitude is reserved for my 
dearest family. This journey would not have been possible without the support of my 
beloved wife. I think they would be delighted to see the completion of this thesis. To 
them, my appreciation never ends. 
  
v 
 
 
 ABSTRACT 
Formation of advanced glycation end products (AGEs) under hyperglycemic 
condition in diabetes mellitus results in micro/macro-angiopathy disorders. Juice, 
leaves, or peel of pomegranate have shown antioxidant or antiglycation effects. 
Pomegranate stem barks which are hugely wasted during the pruning season could be a 
good source of phyto-based anti-AGEs.   This study evaluated standardized 
pomegranate stem barks extract in term of antioxidant activity, antiglycation potential 
and also its effect on lipid formation and glucose consumption in 3T3-L1 cells.Various 
extraction conditions were performed including types of solvents, time and type of 
extraction methods.  Phytochemical analysis of extracts was carried by high-
performance liquid chromatography-pulsed amperometric detector (HPLC-PAD), gas 
chromatography-mass spectroscopy and spectrophotometric methods. Evaluation of 
antioxidant activity was performed using 2,2-diphenyl-1-picrylhydrazyl (DPPH), 2,2′-
Azino-bis (3-ethylbenzthiazoline-6-sulfonic acid) (ABTS) and metal chelating activity.  
Anti glycation activity of the extract was evaluated in bovine serum albumin 
(BSA)/glucose or BSA/methylglyoxal (MGO) bioassay systems in presence or absence 
of samples. Antiglycation property was measured by determination of the level of 
formation of fructosamine, protein carbonyl and AGE or loss of thiol group. Also, 
effect of extract on glucose consumption and lipid formation in 3T3-L1 cell line in 
media containing MGO was investigated in vitro. The result showed that eight hour 
extraction with methanol using Soxhlet extraction (SM8) was the best extraction 
process in term of total polyphenolic compounds (59.69 ± 2.913 mg gallic acid 
equivalent (GAE)/g dry weight (DW), DPPH scavenging capacity [half maximal 
effective concentration (EC50) 14.99 ± 1.18 mg/L], ABTS
●+ radical scavenging equal 
to 2.636 mM trolox equivalent antioxidant capacity (TEAC)/100 g DW and metal 
chelation activity (EC50 888.1±48.38). Standardization of SM8 extract by HPLC-PAD 
showed gallic acid as 0.19% and catechin 0.03% of the extract. SM8 extract reduced 
formation of AGE significantly (p<0.01) by 77% in concentration of 250 µg /ml. 
Moreover, it reduced protein carbonyl (60.2%) and fructosamine formation (33.99 %) 
and simultaneously inhibited thiol group loss (by 1.84 folds). The SM8 extract 
increased glucose consumption (by 1.95 folds) in 3T3-L1 cells in glycemic condition. 
In conclusion, it is recommended that pomegranate stem bark extract as a potential 
source of raw material to be further investigated for the development of health 
supplement with AGEs inhibitory properties.  
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 ABSTRAK 
Pembentukan hasil akhir glikation lanjutan (AGEs) berlaku dalam keadaan 
hiperglisemik diabetes melitus menyebabkan gangguan angiopati makro dan mikro. 
Jus, daun atau kulit buah delima telah dilaporkan menunjukkan kesan antioksidan dan 
anti glikation. Sisa kulit batang pokok delima dari musim cantasan ladang pokok 
delima mungkin merupakan sumber bahan asas-fito anti AGEs yang bernilai. Kajian 
ini menilai ekstrak kulit batang pokok delima terpiawai dari segi, aktiviti antioksidan, 
potensi anti glikation dan kesannya terhadap pembentukan lipid dan penggunaan 
glukosa dalam kultur sel 3T3-L1.  Pelbagai keadaan pengekstrakan telah dijalankan 
termasuk jenis pelarut, masa dan kaedah pengekstrakan.  Analisa fitokimia ekstrak 
dijalankan menggunakan kaedah kromatografi cecair berprestasi tinggi-pengesan 
amperometrik denyut (HPLC-PAD), kromatografi gas- spektroskopi jisim dan 
spektrofotometrik. Penilaian aktiviti antioksidan telah dijalankan menggunakan 2,2-
difenil-1-pikrilhidrazil (DPPH), 2,2′-azino-bis (3-etilbenztiazolin-6-asid sulfonik) 
(ABTS) dan aktiviti pengkelatan logam. Aktiviti anti glikation bagi ekstrak telah 
dinilai menggunakan sistem bioasai bovin serum albumin (BSA)/glukosa atau 
BSA/metilglioksal (MGO) dengan sampel atau tanpa sampel. Sifat anti glikation 
diukur dengan mengira tahap pembentukan fruktosamina, karbonil protein dan AGE 
atau kehilangan kumpulan tiol. Juga, kesan ekstrak terhadap penggunaan glukosa dan 
pembentukan lipid dalam kultur sel 3T3-L1 mengandungi MGO dikaji secara in vitro. 
Hasil kajian menunjukkan bahawa ekstrak metanol menggunakan kaedah Soxhlet 
selama lapan jam (SM8) merupakan kaedah pengekstrakan terbaik dari segi jumlah 
sebatian polifenolik 59.69 ± 2.913 mg asid galik setara (GAE)/g berat kering (DW), 
keupayaan hapus sisa DPPH [kepekatan berkesan separuh maksimum (EC50) 14.99 ± 
1.18 mg/L], radikal hapus sisa ABTS●+ bersamaan dengan 2.636 mM aktiviti kapasiti 
antioksidan bersamaan trolox (TEAC)/100 g DW dan aktiviti pengkelatan logam (EC50 
888.1 ± 48.38). Pempiawaian ekstrak SM8 menggunakan HPLC-PAD menunjukkan 
nilai asid galik sebanyak 0.19% dan katekin sebanyak 0.03%. Pembentukan AGE 
menurun secara ketara (p<0.01) sebanyak 77% pada kepekatan SM8 250 µg /ml. 
Tambahan pula, ia menurunkan karbonil protein (60.2%) dan pembentukan 
fruktosamina (33.99 %) dan sekaligus merencat kehilangan kumpulan tiol (1.84 kali 
ganda). Ekstrak SM8 meningkatkan penggunaan glukosa (1.95 kali ganda) dalam 
kultur sel 3T3-L1 berkeadaan glisemik. Sebagai kesimpulannya, adalah dicadangkan 
bahawa ekstrak kulit pokok delima merupakan bahan mentah berpotensi untuk dikaji 
secara lebih lanjut sebagai suplemen kesihatan yang mempunyai sifat anti AGEs. 
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CHAPTER 1 
 
 
 
 
 
INTRODUCTION 
 
 
 
 
 
1.1 Research Background 
 
 
Basic source of energy for cells is glucose. However, imbalance of glucose 
level in bloodstream (hypoglycaemia or hyperglycemia) is an origin of many 
metabolic disorders.  Diabetes, Diabetes mellitus, is a factorial metabolic chronic 
disease characterised by elevated blood glucose (hyperglycaemia) and insulin 
deficiency (type I) or resistance (type II) (World Health Organozation, 2011).  
According to World Health Organization (WHO) report, it is estimated that diabetic 
cases raise from 285 million in 2010 to 438 million in 2030.  Consequently, global 
expenditures will increase from $418 billion to at least $561 billion (World Health 
Organozation, 2011).   
 
 
Glycation is a mechanism in which carbonyl group of a reducing sugar binds 
to an amino group of a protein without enzymatic control (Zhang et al., 2009).  In 
diabetic condition with prolong hyperglycemia glycation is occurred in an elevated 
level.  Intermediate compounds with α–dicarbonyl structure such as methylglyoxal, 
3-deoxyglucosone and glyoxal play a distinguished role as advanced glycation end 
product (AGEs) precursors to form stable crosslinked proteins or AGEs which result 
in protein dysfunction (Gugliucci and Menini, 2002, Pazdro, 2010).  Accumulation 
of AGEs in tissues promote disorders such as elasticity and ionic problems in kidney, 
atherosclerotic lesions of arterial walls, chronic renal failure and amyloid fibroids in 
hemodialysis-related amyloidosis, stiffening, angiogenesis, and extracellular matrix 
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accumulation physiology of AGEs (Mendez et al., 2010, Beisswenger, 2010).  AGEs 
contribute to the progression of diabetes complications therefore inhibition of 
formation of AGEs reduces development of the diabetic complications.   
 
 
There are natural and synthetic approaches to control AGEs formation.  
However the synthetic medicines are more specific to target but possess some side 
effects.  In contrast, the natural products have beneficial multifunctional properties 
and if being used in right concentration have no serious side effects.     
Aminoguanidine (AG), phenacylthiazolium bromide, ALT-71, and thiazolidine are 
some synthetic AGEs inhibitor compounds.  Nowadays, AG is only used for in vitro 
and animal study, not human, because of very harmful side effects and refuse in 
clinical trials.  Todays, there is rising interest in application of naturally occurring 
inhibitors as antiglycation agents (Tsuji-Naito et al., 2009).  There is a pile of 
evidence that show antiglycation activities of plants phytochemicals in vivo and in 
vitro.  Antiglycation inhibitory effects of a plant is mostly related to its polyphenolic 
compounds (Peng et al., 2008b).  Noticing that, there are many different 
phytochemicals with thousands of structures spread in plant species, it is reasonable 
to search for finding the more specific compounds for various diseases. 
 
 
Pomegranate is a plant native to southern regions of Caspian Sea in Iran, 
Afghanistan, India and the Mediterranean region.  Pomegranate fruit is a valuable 
source of vitamins and minerals and also is rich in bioactive compounds.  The use of 
pomegranate plant parts like roots, bark, fruit, juice and the leaves as medicine has 
ancient root in traditional medicine system in Iran, China, India and Unani traditional 
medicine.  In folk medicine bark and fruit rind are administered for treatment of 
diseases such as dysentery, diarrhea, piles, bronchitis, biliousness and as an 
anthelmintic (Bagri et al., 2009).  Several studies have been conducted in related to 
the therapeutic properties of this plant.  In pomegranate the major group of 
phytochemical that exert antidiabetic activities are polyphenols, which may be able 
to improve hypoglycemia through mechanisms such as, the inhibition of glucose 
absorption in the gut or of its uptake by peripheral tissues (Huang et al., 2006b). 
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Health benefit of pomegranate phytochemical components such as 
punicalagin, ellagic acid, galoyllglucose, anthocyanins and tannins have exhaustively 
been investigated in vitro and in vivo.  The major phytochemicals in rind and fruit 
juice are galloylglucose, punicalin, ellagic acid and gallic acid.  However aril juice 
contain different types of anthocyanins like cyaniding, delphinidin, 3-glucoside, 
glucoside, 3,5- diglucoside and pelargonidin.  Punic acid, sterols γ-tocopherol have 
been identified in seeds extract.  It has indicated that pomegranate seed extract have 
potential of anti-diarrheal and antioxidant properties (He et al., 2010). 
 
 
Traditionally, medicinal plants have been used for treatment or prevention of 
different diseases.  Based on researches, different parts of pomegranate including 
husk, aril, mesocarp (pulp) and leaves contain phenolic compounds including 
anthocyanins, flavonoids and different types of tannins.  Therapeutic effects of these 
compounds has been documented to play a role as anticancer, lowering blood 
glucose level, preventing cardiovascular disease and lipid peroxidation (Seeram et 
al., 2006). 
 
 
Insulin-mediated signalling pathways have remarkable responsibility in 
glucose metabolism.  Impairment of insulin function causes metabolic disorders and 
diseases like atherosclerosis, diabetes and obesity due to inducing insulin resistance.  
Some authors have demonstrated that elevated level of AGEs inside the cell prevents 
insulin signalling pathway and in this way induces insulin resistance.  Glucose 
regulation in blood is depended to insulin-mediated signalling pathways, thus the 
degree of glucose consumption in fat cells could be considered as a monitor index to 
explain the insulin signalling condition (Peng et al., 2010).  Consequently, perfect 
insulin signalling pathways represent cell glucose consumption capability and vice 
versa.  Antioxidants scavenge reactive carbonyl species (RCS) in different 
mechanisms such as trapping α-dicarbonyl intermediate compounds, metal chelating, 
activation of enzymatic antioxidant system, or neutralizing free radical molecules.  
According to the evidence more than 120 polyphenols have been isolated from 
different parts of pomegranate including root, fruit bark, whole fruit, aril, and flowers 
(Seeram et al., 2006).   
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Autoxidation of glucose in the presence of ion metals generates free radicals 
leading to AGEs formation.  Studies have shown that plant extracts or 
phytochemicals exert antiglycation through several mechanisms such as metal 
chelating, free radical scavenging, interfering in glucose metabolism, mimicking 
insulin activity or increasing insulin secretion (Gurav et al., 2007, Okabayashi et al., 
1990 , Arun and Nalini, 2002, Eshrat and Hussain, 2002, Sajithlal et al., 1998, 
Abdullah et al., 2004, Shen et al., 2012).  Phytochemicals, depends on their 
structures, are able (or unable) to trap reactive carbonyl species, scavenge free 
radicals, prevent autoxidation of glucose or oxidative stress which resulting 
suppression of reactions leading to AGEs formation (Ardestani and Yazdanparast, 
2007).  For instance, in an exhaustive research among 115 compounds only 10 
compounds were able to reduce AGE formation (Rahbar and Figarola, 2003).  
Therefore trying to explore natural AGEs inhibitors seems valuable effort.    
 
 
Different types of synthetic and natural compounds have been introduced and 
used against AGEs activities and formation.  Unfortunately, synthetic compounds 
usually show unfavorable side effects however, natural compounds are safer to use.  
The potential of antiglycation activity of a plant is related to structure of its 
phytochemicals and also the concentration of those phytochemicals in the plant parts 
(Rahbar and Figarola, 2003, Peng et al., 2008a).   
 
 
 
 
 
1.2 Problem Statement 
 
 
The hallmark of diabetes is elevated level of glucose (hyperglycemia).  
Therefore, in diabetic patients formation of AGEs is higher compare to healthy 
peoples.  AGEs contribute in pathogenesis of diabetes complications.  Strategies for 
inhibition of AGEs effects are based on detoxification, inhibition of formation and 
prevention of AGEs accumulation by synthetic or natural AGEs inhibitors.  
Normally, introducing new AGEs inhibitors needs a lot of time and cost which 
unfortunately, most of the time, they are rejected in clinical trials.  Moreover they 
have undesirable side effects.  For example, some antidiabetic medicines which 
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decrease blood glucose level cause fatness in patients because of increasing glucose 
intake and depositing in tissues in form of lipid.  Therefore, there is a lot of attention 
to discovery of phytochemicals as the main natural resources with hope to explore 
potent glycation inhibitors.  Considering to pomegranate, as a fruit rich of 
polyphenols with antioxidant properties, many researchers have been attracted to 
investigate its antiglycation potential as well.    
 
 
An exhaustive literature review was done on therapeutic effects of 
pomegranate on diabetes.  Different parts of the plant including leaves, juice, seed or 
fruit bark (rind, peel) have been examined for biological activities (Seeram et al., 
2006).  Previous works have shown the effect of pomegranate fruit, flower, fruit 
bark, leaves or seed on improvement of diabetes.  Among different therapeutic 
effects of pomegranate plant parts on improvement of diabetes, it was not found 
evidence on the therapeutic effect of pomegranate stem bark on diabetes through 
inhibition of AGEs formation.  Therefore, the study aimed to investigate inhibitory 
effect of pomegranate stem bark on formation of AGEs.  Usually stem barks of trees 
contain bioactive compounds such as polyphenols (Vekiari et al., 2008).  After ends 
of the experimental work of the current study, Nishida et al. (2015) released a patent 
on Maillard reaction inhibitor using some plants including pomegranate (Nishida et 
al., 2015).  They have claimed that pomegranate plant part for example root barks, 
stem bark and fruit, have Maillard reaction inhibitory properties.  However, there is 
no specific detail or information on extraction method, or plant part that they have 
used for they experiments.  Generally, bark contains greater amounts of extractable 
components including monomeric polyphenol such as flavonoids and polymeric 
phenolic compounds like tannins and phenolic acids (Anderson et al., 2004).  In 
pomegranate yearly pruning removes a lot of twigs and stems which, at present, have 
no economical usage.  Therefore, if the stem bark shows good potential of 
antiglycation activity it will be economically valuable because of using of pruning 
residues to provide functional extract for nutraceutical use.  To sum up, antiglycation 
agents from naturally occurring compounds due to relatively lack or low toxicity or 
side effects are more promising nominees to be used in functional food or as a 
nutraceutical or even more, to be developed as a medicine for the treatment of 
diabetes complications and other AGE-induced diseases.   
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1.3 Objectives of the Study 
 
 
Considering the lack of information on effect of pomegranate stem bark extract 
on AGE formation, the study was designed to follow below specific objectives  
 
 
i. To determine the most suitable extraction system for pomegranate stem bark 
with respect to yield of extract, total polyphenolic compounds, total flavonoid 
content and antioxidant activities. 
ii. To develop quality control and standardization of pomegranate stem bark 
extract. 
iii. To examine antiglycation capabilities of pomegranate (Punica granatum) 
stem bark extract on bovine serum albumin (BSA) using glucose and 
methylglyoxal (MGO) as glycating agents in vitro. 
iv. To evaluate the possible anti-obesity activity through adipogenesis and 
glucose consumption activities of 3T3-L1 cells in hyperglycemic condition in 
vitro. 
 
 
 
 
 
1.4 Scope of the Study 
 
 
The study was conducted to evaluate antiglycation activity of pomegranate 
stem bark.  Therefore some experiments were performed to achieve the listed 
objectives in previous section.  In the first step the plant material was subjected to 
quality and safety assessment and phytochemical screening.  In order to introduce an 
efficient extraction processing method, plant extracts were obtained using three 
solvents (methanol 80%, ethanol 80% and pure water) two extraction times (4 and 8 
hours) and two extraction methods (soxhlet and maceration).  In the next step, 
extracts were analysed for determination of total polyphenolic compounds, total 
flavonoids content and volatile compounds and FTIR spectrum.  Then antioxidant 
property of extracts was evaluated using DPPH radical scavenging capacity, trolox 
equivalent antioxidant capacity test and metal chelating activity.  From comparison 
of the different obtained extracts, the most effective extract in term of antioxidant 
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assays, polyphenols and flavonoid contents was chosen for further experiments.  In 
vitro antiglycation properties of the selected extract was evaluated by measurement 
of early, intermediate and advanced glycation products in BSA-glucose and BSA-
MGO systems.  Measurement of protein carbonyl content, thiol loss and 
fructosamine content along with ELISA kit for AGEs were used to determine 
glycation level in BSA-glucose and BSA-MGO systems.  Finally, effect of extract on 
glucose consumption was studied by determination of lipid formation and glucose 
consumption in 3T3L-1 preadipocytes cells exposing to MGO and different 
concentrations of extract.    
 
 
  
 
 
1.5 Significant of the Study 
 
 
This study will be helpful for some different groups and scientific disciplines 
as follow 
 
 
i. Food industry to use the pruning residues (stem bark) for preparing extract 
and use it as a food supplement. 
ii. Antiglycation activity of the stem bark extract may be important for 
amelioration of diabetes complications.  For this reason, present study has a 
significance to introduce a novel candidate to pharmacologist to consider it 
for further researches in area of AGEs control. 
iii. The present work can be considered as an evidence and base for future in 
vivo and then clinical experiments on antidiabetic effects of natural occurring 
compounds such as pomegranate stem bark extract. 
iv. This study could causes farmers sell pruning residues instead of burning it 
and in this way earn some profits.   
  
